A Phase II Open Label Study To Determine The SafetyTolerability And Efficacy Of CV 6504(HCI) In Patients with pancreatic cancer refractory to conventional treatment.

  • Kerr, David (Principal Investigator)
  • Ferry, David (Co-Investigator)

Project Details

Short titleA Phase II Open Label Study To Determine The SafetyTolerability And Efficacy Of CV 6504(HCI) In Patients with pancreatic cancer refractory to conventional treatment.
StatusFinished
Effective start/end date1/09/96 → 31/12/00

Funding

  • TAKEDA CHEMICAL INDUSTRIES LTD (JAPAN)